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Summary Normal human breast tissue maintained as xenografts in female Balb/c (nu/nu) athymic mice is
capable of metabolising N-nitrosodimethylamine (NDMA) to active intermediates that will react with DNA.
Administration of NDMA to mice with slow-release implants of 17p-oestradiol which provide human
physiological (luteal phase) circulating oestrogen levels and increase cell proliferation in the xenograft (Laidlaw
et al., 1992), leads to an apparent increase in the extent of reaction with DNA compared to controls without
oestrogen implants. In mice with oestrogen implants, measurements of the amounts of the promutagenic
lesion, 06-methyl-2'-deoxyguanosine formed in DNA clearly indicated a dose related increase in the extent of
reaction. Detection of 06-methyl-2'-deoxyguanosine using immunohistochemical procedures revealed that the
nuclei of cells of the glandular epithelium, supportive tissue and adipose tissue, in decreasing order of
prevalence, were positively stained for the presence of this DNA lesion. Epithelial cells, which are the putative
target cells for carcinogenesis in the breast, are therefore prone to promutagenic damage as a result of
exposure to an environmental nitrosamine.
Although much of the work carried out with xenografts has
been directed towards assessing the responses of human
tumours, particularly to the effects of cytotoxic drugs (e.g.
Schold et al., 1989; Rofstad, 1990), systems using normal
human tissues provide opportunities to study effects of a
variety of agents on human cells maintained and exposed
under physiological conditions.
Normal human female breast samples taken from patients
undergoing surgery for benign tumours can be transplanted
successfully into the immunologically deficient athymic nude
mouse and the ductal elements of these xenografts respond to
mitogenic stimuli such as oestrogen and progesterone
(McManus & Welsch, 1984; Laidlaw et al., in preparation).
However, when measurements of DNA labelling indices are
made on fresh biopsy material the proliferative capacity is
higher in the samples taken in the latter half of the menstrual
cycle when circulating progesterone (rather than oestrogen)
levels are highest (Potten et al., 1988). Details of mechanisms
leading to these proliferative responses or the effects of tak-
ing samples close to, or distal from breast lesions remain
obscure (Potten et al., 1987) but when samples are dissected a
distance from breast lesions to ensure normal tissue, xeno-
grafts established from these sources responded consistently
to increased circulating levels of oestrogen and not to pro-
gesterone. In these studies a progressive 4-5-fold increase in
the proliferative capacity of the ductal epithelium was
observed in response to oestradiol (Laidlaw et al., in prepara-
tion).
As current theories ofhuman carcinogenesis implicate both
carcinogen exposure and host responses (e.g. Pitot, 1990) the
xenograft system potentially offers an experimental approach
by which to test some of the observations made via
epidemiological approaches and importantly to identify cells
at risk within the tissue. Only limited progress has been made
so far in this direction. For example, treatment of human
skin xenografts with the direct acting benzo(a)pyrene diol-
epoxide I, an activated form of benzo(a)pyrene, led to the
formation of higher levels of the major adduct N2-
deoxyguanosine in the DNA of the epidermis than of the
dermis. When the parent hydrocarbon was administered no
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differences in adducts levels were detected. In this system,
modification of the efficacy of reaction with DNA was
observed when xenografts were pretreated with allantoin or
anthralin and thereby increasing levels of both the major and
minor DNA adducts (Yohn et al., 1988;. Kurian et al., 1989).
In the present study, normal human female breast xeno-
grafts maintained with, or without, increased circulating
levels of oestrogen have been exposed to the environmental
nitrosamine, N-nitrosodimethylamine (NDMA). A nitro-
samine was employed because these agents are ubiquitous in
the human environment and NDMA is commonly found in
such situations (Bartsch & Montesano, 1984). NDMA may
arise from both exogenous and endogenous sources as well as
from the metabolism of certain drugs (Margison & O'Con-
nor, 1990) and together with other environmental factors
could be associated with the multifactorial aetiology ofbreast
cancer.
Evidence now indicates that an interaction of exposures to
environmental carcinogens and inherent tissue susceptibility
combine to influence not only cancer incidence but also the
biological behaviour of the neoplasms induced (Harnden,
1990). Indeed, in breast tissue, exposure to environmental
carcinogens and reproductive hormone-mediated tissue susc-
eptibility are both implicated in breast cancer risk (Krieger,
1989). In the following studies radioimmunoassays (Wild et
al., 1983; O'Connor et al., 1988) have been used to detect the
formation of adducts in the DNA of breast xenografts main-
tained in animals given NDMA. Immunohistochemical pro-
cedures (O'Connor et al., 1988; Fan et al., 1989, 1990) have
also been used to detect the promutagenic lesion o6-
methylguanine in the DNA of cells of the breast acini. These
observations indicate that environmental alkylating agents
can act at the level of specific cells in breast tissue and that
these could be targets for the deleterious and carcinogenic
effects of these agents (Saffhill et al., 1985; Margison &
O'Connor, 1990).
Materials and methods
N-nitrosomethylurea (NMU); 3',3'-diaminobenzidine (DAB),
collagenase Type IV, hyaluronidase Type III, bis-benzamide
(Hoeschst 33258) and 1713-oestradiol were obtained from
Sigma, Poole, Dorset, UK; Salistic 382, Medical Grade was
from Dow Corning Corporation, Michigan, USA and N-
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nitrosodimethylamine (NDMA) was purchased from East-
man Kodak Ltd, Kirby, Lanc, UK. Goat anti-rabbit
immunoglobulins (GAR), normal goat serum (NGS) and
horseradish peroxidase-anti-peroxidase (PAP) complex were
supplied by Dako Ltd, High Wycombe, Bucks, UK.
Histologically normal, nulliparous human female breast
tissue was obtained during surgical resection. Tissue was
taken adjacent to benign breast lesions (usually fibro-
adenomas), from 20-30 year old patients with approval of
the Christie Hospital (NHS) Trust ethical committee. The
tissue was cut into 2 mm3 fragments and implanted at eight
sites dorso-laterally under the skin of 6-10 week old female
Balb/c nu/nu mice (25-30 g body weight); each mouse
received 8 pieces of tissue from the same patient.
17P-Oestradiol was mixed with Salistic emulsion (1:12.5;
w/w) to prepare slow-release pellets that were placed under
the dorsal skin close to the base of the tail to provide a
serum oestradiol concentration of 1000-2000 pmoles 1`
(human luteal phase physiological levels; Gannong, 1985) for
7 days prior to carcinogen treatment. This is at least an order
of magnitude higher than the endogenous mouse hormone
level which could not readily be detected by radioimmuno-
assay.
NMU was taken up in a minimal amount of dimethyl-
sulphoxide for dispersion in saline and NDMA was diluted
in normal saline; both were administered intraperitoneally as
indicated in the text between 10.30 am-12.00 noon. Two
animals, one with and one without oestrogen treatment, were
given NMU (100 mg kg-') and killed after 2 h. NDMA
(10 mg kg-1) was given to four mice, two with and two
without oestrogen treatment which were killed after 4 h.
Tissues from these animals were fixed in 70% ethanol and
used for immunohistochemistry (IHC). Subsequently, two
groups of 12 and eight mice, both maintained on oestrogen,
were given NDMA 10 mg kg-' or 20 mgkg-' respectively.
Xenografts from these animals were frozen in liquid nitrogen
and stored at - 70°C for DNA isolation, except for one
xenograft from each mouse which was fixed in 70% ethanol
for IHC. As a preliminary to these experiments, nude mice
and BDF1 (C57B1/6J x DBA2) mice were given NDMA at 5,
10 and 20 mg kg-' (i.p.); after 4 h liver, kidney and lung were
removed for DNA preparation and for ethanol fixation (as
above).
DNA preparation and radioimmunoassays
In order to loosen the dense connective tissue, xenografts
were first incubated with hyaluronidase (0.1%, w/v) and
collagenase (0.05%; w/v) in PBS containing 5 mM CaC12 for
1 h at 37°C. Grafts were then homogenised and DNA was
prepared by the phenol method (Kirby & Cook, 1967). DNA
was digested enzymically and separated by Aminex A7
chromatography. Amounts of 06-MedG eluted from the col-
umn were estimated by radioimmunoassay (three separate
determinations) using a monoclonal antibody to 06-MedG
and amounts of the common purine deoxynucleosides were
measured by spectrophotometry. Details of these procedures
were given earlier (Wild et al., 1983; Saffhill et al., 1988;
O'Connor et al., 1988).
Immunohistochemicalprocedures
Overnight, ethonol-fixed tissues were embedded in paraffin
and sectioned at 3 ytm. After dewaxing and rehydration, sec-
tions were treated with 70 mM NaOH for 30 s to denature the
DNA and exposed overnight at 4°C to the primary antibody
(rabbit anti-O6-methyl-2'-deoxyguanosine; Wild et al., 1983;
Saffhill et al., 1988; O'Connor et al., 1988) diluted 1:4000 in
phosphate buffered saline (PBS). Sections were then
incubated with GAR (1:50 in 10% normal mouse serum
diluted with PBS) for 45 min at RT, washed in PBS and
incubated with rabbit PAP-complex (1:400 in PBS) at RT for
a further 45 min. Incubations with GAR and PAP-complex
were repeated, each for 15 min, after first washing with PBS.
Investigations of the use of the polyclonal primary antibody
have demonstrated the following (i) it has a high specificity
for 06-MedG vs other alkylated and common nucleosides
(Wild et al., 1983); (ii) it binds only weakly to control,
unalkylated DNA (Saffhill et al., 1988); (iii) it is specific for
06-MedG in nuclear DNA (O'Connor et al., 1988); (iv)
denaturation of DNA by brief exposure to alkali does not
impair the affinity of the chromatin-DNA complex for
haematoxylin and the primary antibody penetrates to bind
uniformly with alkylated chromatin DNA throughout the
sectioned nuclei as determined by laser scanning microscopy
(Fan et al., 1989) and (v) nuclei in control sections from
animals not given an alkylating agent are negative but some
background staining occurs in the cytoplasm, as also occurs
in sections from animals treated with alkylating agents (Fan
et al., 1989, 1990). The following test procedures were carried
out using xenografts and liver from the same animals given
NDMA and, rat stomach from animals given N-methyl-N'-
nitro-N-nitrosoguanidine as a further control on which exten-
sive IHC experience had been gained (O'Connor et al., 1991).
Nuclei of the nitrosamine exposed tissues were negatively
stained when (i) the primary antibody was replaced with
12.5% bovine serum albumen, an equivalent dilution of nor-
mal rat serum or, primary antibody preadsorbed with o6-
methyl-2'-deoxyguanosine; (ii) the sodium hydroxide de-
naturation step and/or the primary antibody exposure was
omitted from the procedure and (iii) a pancreatic DNase I
incubation was included prior to exposure to the primary
antibody. Nuclei remained positively stained for 06-MedG
when (i) sections were pre-incubated with yeast RNase (but
not when DNase I was included at this stage); (ii) sections
were pre-adsorbed with NGS before exposure to the primary
antibody and (iii) when 0.5% Triton X-100 was included in
the PBS washes. The latter had no effect on nuclear staining
but slightly reduced the background cytoplasmic staining.
Fluorescent stainingprocedures
Graft sections were incubated for 1 min in a solution con-
taining Hoechst 33258 (4fgml-') in PBS, rinsed in water and
mounted in Mcllvaine's buffer (pH 5.5) (Cunha & Vanders-
lice, 1984).
Results
Preliminary observations
Normal animals Initially, in the absence of such inform-
ation, nude mice were examined for their susceptibility to
NDMA toxicity and their capacity to activate NDMA for
reaction with DNA. NDMA was well tolerated at the doses
used (5-20 mg kg-') and the largely similar extent of forma-
tion of 06-MedG in DNA in the tissues of BDF, vs nude
mice indicated that the agent was being metabolised to a
similar extent in both strains. For example, in the liver of the
nude mouse reaction with DNA after a dose of 10mgkg-'
was 125 ,Lmoles 06-MedG mole-1 dG vs 95tmoles mole-'
dG in the liver of the BDF, mouse. The extent of reaction in
the DNA of lung and kidney at this dose was corres-
pondingly lower (19 and 13 1moles 06-MedG/mole dG
respectively in the BDF1 mice and 16 and 8 Lmoles 06_
MedG/mole-' dG, respectively in the nude mice).
Graft bearing animals A series of enabling experiments were
then carried out with mice bearing xenografts, maintained
with or without oestrogen. Examination of ethanol-fixed
paraffin sections from mice given NMU (100 mg kg-'; i.p.)
showed that all cells were positively stained for 06-MedG,
irrespective of the hormone treatment. When this was
repeated using NDMA (10 mg kg-'; i.p.) the staining for
06-MedG was heterogeneous between cells, but more cells
were stained and the staining was markedly stronger in the
animals given an oestrogen implant. In subsequent experi-
ments therefore only animals maintained on oestrogen were
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Amounts of00-MedG in DNA ofxenografts
Figure 1 shows the formation of 06-MedG in xenograft
DNA in the range 5-34tLmolesmoles-' dG following treat-
ment with NDMA, indicating that the nitrosamine had been
metabolised to an active form by the cells of the xenograft
tissue. The 06-MedG level increased with the dose of NDMA
but was not directly proportional to the dose.
Immunohistochemical localisation ofmethylated cells
Nuclei staining positively for 06-MedG were present in cells
of the glands, supportive fibrous tissue and adipose tissues in
decreasing order of prevalence (Figure 2). Staining was, how-
ever, heterogeneous. For example among the glands, staining
varied from all cells being positively stained to a few cells
positively stained, whilst a few of the glands were completely
negative. Heterogeneity was also observed between the
various xenografts and -10-15% of these contained no
methylated cells at either dose. The presence of positive
staining for 06-MedG indicated that some cells, particularly
those of the glandular epithelium (see Figure 2), were capable
of activating NDMA and thereby becoming potential targets
for the action of the nitrosamine. Some mouse fibroblasts at
the periphery of the dissected xenografts also had nuclei
stained positively for 06-MedG.
Cellularity ofxenografts
Sections were also stained with the fluorescent dye Hoechst
33258 in order to identify cells of murine or human origin
(Figure 3). Murine cells, identified by the presence of several
small intensely fluorescent intranuclear bodies (Cunha &
Vanderslice, 1984), were relatively few in number and were
present mainly at the outer extremities of the graft, with very
few invading the tissue of the graft itself. Overall, murine
cells represented no more than 5-10% of the cells in sections
of the grafts. The majority of the cells in the xenografts had
more or less homogeneous staining across the nuclei (i.e.
were of human type). Almost all of the cells of the glandular
tissue had nuclei with human staining characteristics. It was
evident that the majority of the cells in the dissected xeno-
grafts were of human origin and that murine cells had not
invaded the regions containing viable acini.
Discussion
Preliminary experiments indicated that the nude mouse was
no more susceptible to NDMA toxicity than normal mice
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Figure 1 Amounts of 06-methyl-2'-deoxyguanosine formed in
the DNA of human breast xenografts 4 h after administration of
two different doses of N-nitrosodimethylamine to the host
animals. Vertical lines indicate the range of triplicate analysis.
Figure 2 Immunohistochemical detection of 06-methyl-2'-
deoxyguanosine in the cells of the glands and other elements in a
section of a human breast xenograft maintained in a nude mouse
for 14 days and pretreated with 17,-oestradiol for 7 days prior to
giving NDMA (20mgkg-'); tissues were sampled 4h later. Sec-
tion of a gland from a control animal given saline, (a); or after
nitrosamine treatment, (b); ( x 260).
and therefore could be used to study the effects of NDMA
over a range of doses (Zaidi & O'Connor, in preparation ).
When the direct acting agent NMU was administered to
graft bearing animals and the grafts were examined immuno-
histochemically, the nuclei of all the cells contained 06-MedG
indicating that the agent was distributed freely throughout
the graft and could interact with nuclear DNA. The effects of
NDMA were then examined in the presence or absence of an
oestrogen release-pellet. When higher circulating levels of
oestrogen were present, the increased frequency and staining
intensity of the graft cell nuclei suggested that the presence of
17p-oestradiol had increased the extent to which NDMA is
metabolised to its active intermediate and for this reason
subsequent experiments were carried out in animals given
oestrogen release-pellets.
In animals with oestrogen implants and then given NDMA
(10 or 20mgmg'), the extent of formation of 06-MedG in
DNA, as measured by RIA, although dose related, was not
directly proportional to dose (Figure 1). The dispropor-
tionately low level at the lower dose might be due to inter-
individual variations in the metabolism of NDMA but as 12
animals, each with 8 grafts were used, this seems an unlikely
possibility. It is more likely to be explained either by a DNA
repair process or to a detoxification mechanism which is
efficient at low doses. An 06-methylguanine-DNA alkyltrans-
ferase (ATase) protein has been detected in human breast
tissue at levels of 221 ± 2.1 (SEM) fmol per mg protein or
10.07 ± 0.98 (SEM) fmol per ;tg DNA; although there were
large individual variations in activity no differences were
found between samples of neoplastic and non-neoplastic
origin (Cao et al., 1991). As repair by this protein occurs by82 S.N.H. ZAIDI et al.
Figure 3 Fluorescence microscopy of a section of a human
breast xenograft maintained in a nude mouse given N-
nitrosodimethylamine (20 mg kg-') 4 h before sampling. This was
stained using Hoecht 33258 to demonstrate nuclear chromatin;
low power view of the outer edge of a section of a single graft
showing an acinius, (a); high power view of the nuclei of the
same acinus cut in transverse section, (b); and of mouse cell
nuclei from the periphery of the graft, (c); the arrows indicate
nuclei in sharp focus to show the intensely fluorescent bodies of
the murine nucleus. These differences between cells of murine and
human origin are more readily observed by adjusting up and
down through the plane of focus (see text).
an auto-inactivating process (Saffhill et al., 1985) a limitation
in the numbers of molecules of ATase would limit the deple-
tion of 06-MedG adducts in DNA, thereby saturating the
repair process at higher doses of NDMA but not at the lower
doses. From these studies, however, it is not possible to
determine which cell types (see below) might be responsible
for the lower level of 06-MedG at this lower dose either by a
DNA repair mechanism as indicated above or by a
detoxification process which leads to a lower level of DNA
damage.
Sections of xenografts from the same experiments were
extensively examined by immmunohistochemistry, including a
range of control procedures to exclude staining artefacts.
This revealed a heterogeneous distribution of 06-MedG posi-
tive cells. The variability between cells of the samne or
different types and between grafts were similar to the differ-
ences seen in laboratory animals for the in vivo capacity to
metabolise agents such as NDMA (Fan et al., 1990), afla-
toxin B, (Wild et al., 1990) and N-nitroso-bis(2-oxopropyl)-
amine (Bax et al., 1991). Whilst 06-MedG positive nuclei
were found in all cell types i.e. cells of the acini, myoepi-
thelium, fibrous tissue, adipose cells and residual mouse cells,
most prominent were the cells of the glandular epithelium
(Figure 2). An examination of the cellularity of these xeno-
grafts showed that the cells of murine origin were restricted
essentially to the edges of the graft and constituted no more
than 5-10% of the cells in the dissected graft (Figure 3).
From these observations it is evident that the cells of the
xenograft are freely accessible to circulating carcinogens and
the system therefore provides a model for the study of some
of the biological effects of these agents. Comparison of the
effects of NMU and NDMA also indicates those human cells
within the graft which have the capacity to metabolise this
class of agents. Although the extents of reaction with DNA
shown in Figure 1 are attributable to reactions with all cell
types (see above), including the cells of murine origin, it is
evident that the breast epithelial cells account for at least a
significant part of this.
The localisation of promutagenic DNA damage in cells of
breast tissue which are the putative targets for breast carci-
nogenesis has the following implications: Firstly, these
xenografts appear to respond to oestrogen, not only by
apparently increasing the capacity for NDMA metabolism
but also by increasing the rate of DNA synthesis and cell
division (Laidlaw et al., in preparation). The system therefore
has the capacity for initiation by the induction of chemical
mutations i.e. GC-*AT transitions arising from the replica-
tion of DNA templates containing 06-MedG (Saflhill et al.,
1985). As oestrogens are also deemed to act as promotors of
carcinogenesis in breast tissue (Howell, 1989) it is possible
that grafts maintained and treated in this way may provide a
model system for human breast carcinogenesis, at least for
the earliest stages of development.
Secondly, they also provide an opportunity to test
rigorously the apparent ability of oestrogens such as 17p-
oestradiol to increase the capacity of breast tissue for the
metabolism of environmental carcinogens such as NDMA. A
detailed study of this process and the extent of individual
variability may contribute towards an understanding of risk
prediction.
Although the properties exhibited by these grafts may be
attenuated to a degree in relation to those present in vivo
they nevertheless provide important indications for
mechanisms in breast carcinogenesis and for future investiga-
tions.
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